Top 10 Countries for China Pharmaceutical Exports—Based on DengYueMed’s Global Business Insights
China’s pharmaceutical export markets span North America, Europe, Asia, Latin America, Africa, and Oceania. Pharmaceutical exports from China are expanding from traditional APIs and generic medicines to finished formulations, biological products, and innovative medicines.
Based on China’s pharmaceutical export trends over the past three years and DengYueMed’s years of experience in the global pharmaceutical supply chain, this article analyzes 10 representative overseas markets, including the United States, France, India, Germany, and Brazil.
Overview of the Top 10 Countries for China Pharmaceutical Exports
| Country | Market Position | Key Features of China Pharmaceutical Exports |
|---|---|---|
| 🇺🇸 United States | Large and mature global pharmaceutical market | Diverse exports of finished formulations, biological products, and other pharmaceutical products |
| 🇫🇷 France | Major European pharmaceutical production and consumption market | Finished formulations, APIs, and other pharmaceutical products |
| 🇩🇰 Denmark | Important Nordic pharmaceutical industry and trade market | Finished formulations, biological products, and other pharmaceutical products |
| 🇮🇳 India | Major global pharmaceutical manufacturing market | Strong supply of APIs, pharmaceutical intermediates, and manufacturing materials |
| 🇩🇪 Germany | European pharmaceutical, R&D, and distribution hub | Finished formulations, medical dressings, blood products, immunological products, and others |
| 🇧🇷 Brazil | Major Latin American pharmaceutical market | Finished formulations, APIs, specialty medicines, and other pharmaceutical products |
| 🇯🇵 Japan | Mature Asian pharmaceutical market | Finished formulations, medical dressings, biological products, and other pharmaceutical products |
| 🇦🇺 Australia | Major pharmaceutical market in Oceania | Retail-packaged medicines, medical dressings, biological products, and others |
| 🇬🇧 United Kingdom | International pharmaceutical R&D and commercialization market | Finished formulations, APIs, and other pharmaceutical products |
| 🇿🇦 South Africa | Regional pharmaceutical market in Southern Africa | Finished formulations, medical dressings, and other pharmaceutical products |
1. United States: Largest Market with an Expanding Product Mix
The United States is one of the most significant markets among the top 10 countries for China pharmaceutical exports.
According to WITS, China’s pharmaceutical exports to the U.S. reached approximately US$2.194 billion in 2023, US$2.618 billion in 2024, and US$2.521 billion in 2025, remaining above US$2.5 billion in 2025.
The U.S. has one of the world’s largest pharmaceutical markets, covering innovative, biological, generic, and specialty medicines. China’s exports now extend beyond APIs and generics to finished formulations, biological products, and other pharmaceutical products.
As Chinese pharmaceutical companies expand globally, the U.S. market is becoming increasingly important for innovative drug globalization and industry cooperation. DengYueMed maintains long-term relationships with U.S. partners and monitors pharmaceutical supply and international supply chain needs.
2. France: An Important Gateway to the European Pharmaceutical Industry
France is an important pharmaceutical production and consumption market in Europe and a major destination for China pharmaceutical exports. From 2023 to 2025, China’s pharmaceutical exports to France reached approximately US$688 million, US$435 million, and US$1.346 billion, respectively.
The three-year trend shows that exports in 2025 were significantly higher than in the previous two years.
Products exported from China to France include finished formulations, APIs, and other pharmaceutical products.
France’s importance extends beyond domestic demand to European pharmaceutical distribution and industry cooperation, making it an important market for DengYueMed’s understanding of the European pharmaceutical landscape.
3. Denmark: An Important Nordic Pharmaceutical Industry and Trade Market
Denmark is an important pharmaceutical industry and trading market in the Nordic region. It is also among the Top 10 Countries for China Pharmaceutical Exports.
From 2023 to 2025, China’s pharmaceutical exports to Denmark reached approximately US$475 million, US$994 million, and US$1.182 billion, respectively, growing for two consecutive years and gaining importance among China’s export destinations.
China-Denmark pharmaceutical trade covers finished formulations, biological products, and other pharmaceutical products. Denmark’s mature pharmaceutical industry and international supply networks also make it an important link between Chinese and European pharmaceutical markets.
4. India: Strong Focus on APIs and Pharmaceutical Supply Chain Cooperation
India is a major global producer of generic medicines and finished formulations, while its pharmaceutical industry also relies on imported APIs and raw materials.
A 2026 NITI Aayog analysis shows that China is a major source for several API categories imported by India, with high dependence on Chinese supply for some antibiotic APIs and nitrogen heterocyclic compounds.
As a result, China pharmaceutical exports to India have a strong supply-chain focus, covering APIs, pharmaceutical intermediates, antibiotic raw materials, vitamins, and other manufacturing materials.
India’s formulation capacity and China’s raw material supply also create strong supply-chain complementarities. As a China pharmaceutical exporter, DengYueMed closely follows cooperation between raw material suppliers and pharmaceutical manufacturers.
5. Germany: Strong Role for Finished Pharmaceutical Formulations
Germany is a major European center for pharmaceutical manufacturing, R&D, and distribution. Compared with markets where APIs are more prominent, finished pharmaceutical formulations account for a notable share of China’s pharmaceutical trade with Germany.
Additional trade data show that China’s exports to Germany include medical dressings, blood and immunological products, and other pharmaceutical products.
This indicates that Chinese pharmaceutical products entering Germany cover multiple areas, from finished medicines to specialized pharmaceutical products, reflecting the growing internationalization of China’s pharmaceutical manufacturing and supply capabilities.
6. Brazil: A Latin American Market with Long-Term Attention and Cooperation
Brazil is one of the larger Latin American markets among the top 10 countries for China pharmaceutical exports.
In 2025, China exported approximately US$350 million in pharmaceutical products to Brazil. Brazil itself has one of the largest pharmaceutical markets in Latin America, with substantial demand for generic medicines, prescription medicines, OTC products, and biological products.
Brazil is also an important country for DengYueMed’s long-term market focus and pharmaceutical supply chain cooperation. Based on business experience, China-Brazil pharmaceutical trade covers finished formulations, APIs, specialty medicines, and other pharmaceutical products.
Local and multinational pharmaceutical companies, along with the public healthcare system, drive demand, creating opportunities for Chinese companies in finished pharmaceuticals, raw materials, and specialty products.
7. Japan: Quality-Focused Demand in a Mature Asian Market
Japan is a mature pharmaceutical market in Asia with stable demand for imported pharmaceutical products. In 2025, Japan’s total pharmaceutical imports exceeded US$32.4 billion, while China’s pharmaceutical exports to Japan were approximately US$313 million.
China’s pharmaceutical exports to Japan include finished formulations, pharmaceutical-related products, medical dressings, and certain biological products.
Unlike India, where pharmaceutical supply chain cooperation is particularly prominent, the Japanese market places greater emphasis on product quality, manufacturing management, technical documentation, and supply stability. Japan is therefore also an important market for observing the internationalization of China’s pharmaceutical industry.
8. Australia: An Import-Oriented Market with Cross-Border Supply Chain Needs
Australia is an important pharmaceutical market in Oceania, with a relatively high level of participation in pharmaceutical imports. Its imports from China include retail-packaged medicines, medical dressings, biological products, and other pharmaceutical products.
Because Australia is geographically distant from China, its market characteristics involve not only product demand but also cross-border logistics capabilities.
For biological products and other temperature-sensitive medicines, 2–8°C cold-chain management, temperature recording, packaging, and batch tracking are particularly important during transportation.
DengYueMed also continues to monitor these long-distance cold-chain logistics scenarios as part of its international pharmaceutical supply chain activities.
9. United Kingdom: Pharmaceutical Trade and Innovative Drug Globalization
The United Kingdom has a mature pharmaceutical R&D, clinical research, and commercialization system and is an important global pharmaceutical market.
In 2025, the UK’s pharmaceutical exports were approximately US$27.54 billion, while China’s pharmaceutical exports to the UK were approximately US$406 million.
Current China-UK pharmaceutical trade covers finished formulations, APIs, and other pharmaceutical products.
At the same time, as Chinese innovative pharmaceutical companies expand overseas clinical development and licensing partnerships, the role of the UK is gradually extending beyond traditional pharmaceutical trade to innovative drug R&D, international clinical development, and commercialization cooperation.
10. South Africa: A Regional Supply Chain Hub for Africa
South Africa is an important regional pharmaceutical market in Africa. Although its market is significantly smaller than those of major markets in Europe, North America, and Asia, its regional supply chain role remains noteworthy.
South Africa also exports pharmaceutical products to neighboring countries, including Namibia, Botswana, Mozambique, Zimbabwe, and Zambia. Its significance therefore extends beyond domestic demand to pharmaceutical distribution and supply networks across Southern Africa.
China’s exports to South Africa include finished formulations, medical dressings, pharmaceutical-related products, and certain biological products.
How Does DengYueMed View Global Pharmaceutical Markets as a China Pharmaceutical Exporter?
DengYueMed has long been involved in global pharmaceutical supply chain activities, with continued attention to key stages of the China pharmaceutical supply chain, including supplier screening, qualification assessment, quality documentation, international logistics, import procedures, and cold-chain transportation.
Based on years of business experience, China pharmaceutical exports are no longer simply about cross-border product trade.
The top 10 countries for China pharmaceutical exports also reflect differences in market demand, regulatory environments, and supply chain structures.
- United States & Japan: Greater emphasis on quality systems and registration requirements.
- European markets: Stronger focus on regulatory compliance and supply chain management within a harmonized framework.
- India: A clear connection between APIs, finished formulations, and pharmaceutical manufacturing.
- Brazil & South Africa: More distinctive regional pharmaceutical supply chain characteristics.
DengYueMed therefore views the global pharmaceutical market not as a single uniform market, but as an international network shaped by different countries, regulatory systems, pharmaceutical demands, and supply chain structures.
Conclusion—Understanding China Pharmaceutical Export Markets
China pharmaceutical exports are expanding from traditional API and generic medicine trade into finished formulations, biological products, specialty medicines, and innovative medicines, while overseas markets are becoming increasingly diverse.
Market demand and supply chain characteristics vary from country to country. Pharmaceutical globalization is therefore no longer simply about exporting products; it also involves supplier selection, quality management, import procedures, and international logistics.
As a China pharmaceutical exporter, Hong Kong-based DengYueMed supports pharmaceutical sourcing, supply chain coordination, import and export, and specialty and cold-chain services, connecting Chinese pharmaceutical resources with global healthcare markets.
Explore China Pharmaceutical Export Solutions
FAQ about Top 10 Countries for China Pharmaceutical Exports
Which countries are major markets for China pharmaceutical exports?
The United States, France, Denmark, India, Germany, Brazil, Japan, Australia, the United Kingdom, and South Africa are representative markets for China pharmaceutical exports.
What pharmaceutical products does China export?
China exports a wide range of products, including APIs, generic medicines, finished formulations, biological products, specialty medicines, and innovative medicines.
What factors affect China pharmaceutical exports to different countries?
Market demand, regulatory requirements, product registration, supplier qualifications, and international pharmaceutical supply chain conditions all influence exports.
What role does DengYueMed play in China pharmaceutical exports?
As a China pharmaceutical exporter, DengYueMed supports pharmaceutical sourcing, supply chain coordination, import and export processes, and specialty and cold-chain pharmaceutical services.
How does the China pharmaceutical export market differ by country?
Each market has different regulatory, product, and supply chain characteristics, from quality and registration requirements in mature markets to API-focused supply chains in India and regional distribution networks in Africa.
